These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34663428)

  • 41. Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors.
    Baschant U; Rauner M; Balaian E; Weidner H; Roetto A; Platzbecker U; Hofbauer LC
    Haematologica; 2016 Dec; 101(12):1499-1507. PubMed ID: 27540134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity.
    Chen K; Liu J; Liu S; Xia M; Zhang X; Han D; Jiang Y; Wang C; Cao X
    Cell; 2017 Jul; 170(3):492-506.e14. PubMed ID: 28753426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling.
    Jiang C; He C; Wu Z; Li F; Xiao J
    Biochem Biophys Res Commun; 2018 Jul; 502(3):382-388. PubMed ID: 29842882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis.
    Xie Y; Sahin M; Wakamatsu T; Inoue-Yamauchi A; Zhao W; Han S; Nargund AM; Yang S; Lyu Y; Hsieh JJ; Leslie CS; Cheng EH
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenomic landscape of enhancer elements during Hydra head organizer formation.
    Reddy PC; Gungi A; Ubhe S; Galande S
    Epigenetics Chromatin; 2020 Oct; 13(1):43. PubMed ID: 33046126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia.
    Bu J; Chen A; Yan X; He F; Dong Y; Zhou Y; He J; Zhan D; Lin P; Hayashi Y; Sun Y; Zhang Y; Xiao Z; Grimes HL; Wang QF; Huang G
    Leukemia; 2018 Apr; 32(4):890-899. PubMed ID: 29249820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of functional cooperative mutations of SETD2 in human acute leukemia.
    Zhu X; He F; Zeng H; Ling S; Chen A; Wang Y; Yan X; Wei W; Pang Y; Cheng H; Hua C; Zhang Y; Yang X; Lu X; Cao L; Hao L; Dong L; Zou W; Wu J; Li X; Zheng S; Yan J; Zhou J; Zhang L; Mi S; Wang X; Zhang L; Zou Y; Chen Y; Geng Z; Wang J; Zhou J; Liu X; Wang J; Yuan W; Huang G; Cheng T; Wang QF
    Nat Genet; 2014 Mar; 46(3):287-93. PubMed ID: 24509477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptional control in cardiac progenitors: Tbx1 interacts with the BAF chromatin remodeling complex and regulates Wnt5a.
    Chen L; Fulcoli FG; Ferrentino R; Martucciello S; Illingworth EA; Baldini A
    PLoS Genet; 2012; 8(3):e1002571. PubMed ID: 22438823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Setd2 is associated with strontium-induced bone regeneration.
    Jia X; Long Q; Miron RJ; Yin C; Wei Y; Zhang Y; Wu M
    Acta Biomater; 2017 Apr; 53():495-505. PubMed ID: 28219807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
    Zhang YL; Sun JW; Xie YY; Zhou Y; Liu P; Song JC; Xu CH; Wang L; Liu D; Xu AN; Chen Z; Chen SJ; Sun XJ; Huang QH
    Cell Res; 2018 Apr; 28(4):476-490. PubMed ID: 29531312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation.
    Edmunds JW; Mahadevan LC; Clayton AL
    EMBO J; 2008 Jan; 27(2):406-20. PubMed ID: 18157086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells.
    Sheng Y; Ji Z; Zhao H; Wang J; Cheng C; Xu W; Wang X; He Y; Liu K; Li L; Voeltzel T; Maguer-Satta V; Gao WQ; Zhu HH
    Cell Prolif; 2019 Jul; 52(4):e12611. PubMed ID: 31054182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.
    Li H; An J; Wu M; Zheng Q; Gui X; Li T; Pu H; Lu D
    Oncotarget; 2015 Sep; 6(29):27847-64. PubMed ID: 26172293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Trans-Spliced Long Noncoding RNA tsRMST Impedes Human Embryonic Stem Cell Differentiation Through WNT5A-Mediated Inhibition of the Epithelial-to-Mesenchymal Transition.
    Yu CY; Kuo HC
    Stem Cells; 2016 Aug; 34(8):2052-62. PubMed ID: 27090862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Setd2 supports GATA3
    Ding Z; Cai T; Tang J; Sun H; Qi X; Zhang Y; Ji Y; Yuan L; Chang H; Ma Y; Zhou H; Li L; Sheng H; Qiu J
    Nat Commun; 2022 Dec; 13(1):7468. PubMed ID: 36463230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma.
    Zhou Y; Zheng X; Xu B; Deng H; Chen L; Jiang J
    Aging (Albany NY); 2020 Nov; 12(24):25189-25206. PubMed ID: 33223508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wnt5a/FZD4 Mediates the Mechanical Stretch-Induced Osteogenic Differentiation of Bone Mesenchymal Stem Cells.
    Gu Q; Tian H; Zhang K; Chen D; Chen D; Wang X; Zhao J
    Cell Physiol Biochem; 2018; 48(1):215-226. PubMed ID: 30007964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
    Dudakovic A; Camilleri ET; Xu F; Riester SM; McGee-Lawrence ME; Bradley EW; Paradise CR; Lewallen EA; Thaler R; Deyle DR; Larson AN; Lewallen DG; Dietz AB; Stein GS; Montecino MA; Westendorf JJ; van Wijnen AJ
    J Biol Chem; 2015 Nov; 290(46):27604-17. PubMed ID: 26424790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.